{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T19:57:45Z","timestamp":1784231865095,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.antiviral.2019.06.004","type":"journal-article","created":{"date-parts":[[2019,6,15]],"date-time":"2019-06-15T19:03:39Z","timestamp":1560625419000},"page":"203-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss"],"prefix":"10.1016","volume":"168","author":[{"given":"Graciela","family":"Andrei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Van Loon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyne","family":"Lerut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasper","family":"Victoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Meijers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Bammens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sprangers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Gillemot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Fiten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislain","family":"Opdenakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katrien","family":"Lagrou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Kuypers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Snoeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"Naesens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.06.004_bib1","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1093\/jpids\/pit045","article-title":"Antiviral drug-resistance typing reveals compartmentalization and dynamics of acyclovir-resistant herpes simplex virus type-2 (HSV-2) in a case of Neonatal herpes","volume":"3","author":"Bache","year":"2014","journal-title":"J Pediatric Infect Dis Soc"},{"key":"10.1016\/j.antiviral.2019.06.004_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.antiviral.2016.05.020","article-title":"Multidrug-resistant cytomegalovirus infection in a pediatric stem cell transplantation patient","volume":"132","author":"Bauters","year":"2016","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.06.004_bib3","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1111\/ajt.15135","article-title":"Emergence of letermovir resistance in a lung transplant recipient with ganciclovir-resistant cytomegalovirus infection","volume":"18","author":"Cherrier","year":"2018","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.antiviral.2019.06.004_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/rmv.574","article-title":"Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir","volume":"18","author":"Chou","year":"2008","journal-title":"Rev. Med. Virol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1097\/QCO.0000000000000170","article-title":"Approach to drug-resistant cytomegalovirus in transplant recipients","volume":"28","author":"Chou","year":"2015","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib6","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1128\/AAC.03214-14","article-title":"Improved detection of emerging drug-resistant mutant cytomegalovirus subpopulations by deep sequencing","volume":"58","author":"Chou","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2019.06.004_bib7","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1093\/cid\/cis818","article-title":"State-of-the-art monitoring of cytomegalovirus-specific cell-mediated immunity after organ transplant: a primer for the clinician","volume":"55","author":"Egli","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib8","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1097\/TP.0000000000000570","article-title":"Evaluation of low- versus high-dose valganciclovir for prevention of cytomegalovirus disease in high-risk renal transplant recipients","volume":"99","author":"Gabardi","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.06.004_bib9","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/petr.12654","article-title":"Cytomegalovirus transmission in pediatric renal transplant recipients during the window period","volume":"20","author":"Gangopadhyay","year":"2016","journal-title":"Pediatr. Transplant."},{"key":"10.1016\/j.antiviral.2019.06.004_bib10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.jcv.2016.04.017","article-title":"Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients","volume":"80","author":"Garrigue","year":"2016","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib11","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1128\/JCM.01576-08","article-title":"Clinical predictive value of real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples","volume":"47","author":"Goegebuer","year":"2009","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib12","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1097\/QCO.0000000000000409","article-title":"Viral infections in solid organ transplant recipients: novel updates and a review of the classics","volume":"30","author":"Haidar","year":"2017","journal-title":"Curr. Opin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib13","first-page":"526","article-title":"Efficacy and safety of low-dose versus standard-dose valganciclovir for prevention of cytomegalovirus disease in intermediate-risk kidney transplant recipients","volume":"14","author":"Halim","year":"2016","journal-title":"Exp Clin Transplant"},{"key":"10.1016\/j.antiviral.2019.06.004_bib14","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ijid.2017.09.023","article-title":"Preemptive anti-cytomegalovirus therapy in high-risk (donor-positive, recipient-negative cytomegalovirus serostatus) kidney transplant recipients","volume":"65","author":"Hasegawa","year":"2017","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/tid.12609","article-title":"Multicenter evaluation of efficacy and safety of low-dose versus high-dose valganciclovir for prevention of cytomegalovirus disease in donor and recipient positive (D+\/R+) renal transplant recipients","volume":"18","author":"Heldenbrand","year":"2016","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.2174\/187152611797636668","article-title":"The genetic basis of human cytomegalovirus resistance and current trends in antiviral resistance analysis","volume":"11","author":"James","year":"2011","journal-title":"Infect. Disord. - Drug Targets"},{"key":"10.1016\/j.antiviral.2019.06.004_bib17","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.1016\/j.transproceed.2018.03.126","article-title":"Cytomegalovirus status of kidney transplant recipients and cardiovascular risk","volume":"50","author":"Komorowska-Jagielska","year":"2018","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.antiviral.2019.06.004_bib18","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1681\/ASN.2004121113","article-title":"Viral infection in the renal transplant recipient","volume":"16","author":"Kotton","year":"2005","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib19","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/TP.0000000000002191","article-title":"The third international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"102","author":"Kotton","year":"2018","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.06.004_bib20","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1097\/TP.0b013e3181f7c053","article-title":"Cytomegalovirus serostatus pairing and deceased donor kidney transplant outcomes in adult recipients with antiviral prophylaxis","volume":"90","author":"Kuo","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.06.004_bib21","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1086\/342844","article-title":"Analysis and characterization of antiviral drug-resistant cytomegalovirus isolates from solid organ transplant recipients","volume":"186","author":"Lurain","year":"2002","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib22","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1128\/CMR.00009-10","article-title":"Antiviral drug resistance of human cytomegalovirus","volume":"23","author":"Lurain","year":"2010","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.antiviral.2019.06.004_bib23","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/TP.0b013e31821fad25","article-title":"Incidence and outcomes of ganciclovir-resistant cytomegalovirus infections in 1244 kidney transplant recipients","volume":"92","author":"Myhre","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.06.004_bib24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1097\/TP.0000000000000522","article-title":"Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients","volume":"99","author":"Opelz","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.06.004_bib25","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jcv.2006.01.015","article-title":"The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection","volume":"36","author":"Reischig","year":"2006","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib26","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3851\/IMP3129","article-title":"The impact of viral load and time to onset of cytomegalovirus replication on long-term graft survival after kidney transplantation","volume":"22","author":"Reischig","year":"2017","journal-title":"Antivir. Ther."},{"key":"10.1016\/j.antiviral.2019.06.004_bib27","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1128\/JCM.01605-13","article-title":"Detection of cytomegalovirus drug resistance mutations by next-generation sequencing","volume":"51","author":"Sahoo","year":"2013","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib28","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/JCM.43.1.208-213.2005","article-title":"How evolution of mutations conferring drug resistance affects viral dynamics and clinical outcomes of cytomegalovirus-infected hematopoietic cell transplant recipients","volume":"43","author":"Springer","year":"2005","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2019.06.004_bib29","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/TP.0000000000000160","article-title":"Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment","volume":"98","author":"Stern","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.antiviral.2019.06.004_bib30","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/tid.12349","article-title":"Increased risk of breakthrough infection among cytomegalovirus donor-positive\/recipient-negative kidney transplant recipients receiving lower-dose valganciclovir prophylaxis","volume":"17","author":"Stevens","year":"2015","journal-title":"Transpl. Infect. Dis."},{"key":"10.1016\/j.antiviral.2019.06.004_bib31","doi-asserted-by":"crossref","first-page":"168","DOI":"10.18433\/J3805B","article-title":"Effectiveness of valganciclovir 900mg versus 450mg for cytomegalovirus prophylaxis in renal transplantation: a systematic review and meta-analysis","volume":"20","author":"Xin","year":"2017","journal-title":"J. Pharm. Pharm. Sci."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219301093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T12:28:33Z","timestamp":1759062513000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219301093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":31,"alternative-id":["S0166354219301093"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.06.004","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistent primary cytomegalovirus infection in a kidney transplant recipient: Multi-drug resistant and compartmentalized infection leading to graft loss","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.06.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}